Hyderabad: Swaasa, an AI platform to detect COVID-19 and pulmonary TB through analysis of cough sounds, has completed successful clinical validations by the faculty and staff at the Government Hospital of Chest and Communicable Diseases in Visakhapatnam.
Swaasa is a tool to self-test/monitor lung health anywhere, anytime. Since it is a SaMD (Software as a Medical Device) no hardware is required.
The project was undertaken with an objective to develop a point of care COVID-19 and TB triaging, monitoring, and surveillance solution using functional (sound) information collected from the lungs, and advanced Artificial Intelligence technology which can be scalably deployed in the resource-limited low middle-income country (LMIC) settings.
The project was funded by the UK’s Foreign, Commonwealth, and Development Office (FCDO) through C-CAMP (India’s premier life sciences innovation hub). The CTRI registered clinical studies were conducted by the faculty of the Andhra Medical College at the King George Hospital and Government Hospital of Chest and Communicable Diseases.
Dr. Andrew Fleming, the deputy high commissioner of the UK to Andhra Pradesh and Telangana, visited the hospital, which is a teaching hospital under Andhra Medical College, Visakhapatnam, on Saturday and congratulated the staff for successfully completing clinical validations.
He appreciated the extremely promising results achieved under very aggressive timelines. He said he looked forward to the implementation of the solution at scale in the near future.
Source: newsmeter.in
